|
Issue |
Title |
|
Vol 2011, No 4 (2011) |
Eli Lilly |
Abstract
|
Nigel Borshell |
|
Vol 2011, No 5 (2011) |
Eli Lilly |
Abstract
|
Nigel Borshell |
|
Vol 2011, No 6 (2011) |
Eli Lilly |
Abstract
|
Nigel Borshell |
|
Vol 2012, No 1 (2012) |
Eli Lilly |
Abstract
|
Nigel Borshell |
|
Vol 2012, No 2 (2012) |
Eli Lilly |
Abstract
|
Nigel Borshell |
|
Vol 2012, No 3 (2012) |
Eli Lilly |
Abstract
|
Nigel Borshell, Taskin Ahmed |
|
Vol 2012, No 4 (2012) |
Eli Lilly |
Abstract
|
Heather Cartwright, Taskin Ahmed |
|
Vol 2013, No 1 (2013) |
Eli Lilly |
Abstract
|
Heather Cartwright, Taskin Ahmed |
|
Vol 2011, No 4 (2011) |
GlaxoSmithKilne |
Abstract
|
Nigel Borshell |
|
Vol 2011, No 1 (2011) |
GlaxoSmithKline |
Abstract
|
Nigel Borshell |
|
Vol 2011, No 2 (2011) |
GlaxoSmithKline |
Abstract
|
Nigel Borshell |
|
Vol 2011, No 3 (2011) |
GlaxoSmithKline |
Abstract
|
Nigel Borshell |
|
Vol 2011, No 5 (2011) |
GlaxoSmithKline |
Abstract
|
Nigel Borshell |
|
Vol 2011, No 6 (2011) |
GlaxoSmithKline |
Abstract
|
Nigel Borshell |
|
Vol 2012, No 1 (2012) |
GlaxoSmithKline |
Abstract
|
Nigel Borshell |
|
Vol 2012, No 2 (2012) |
GlaxoSmithKline |
Abstract
|
Nigel Borshell |
|
Vol 2012, No 3 (2012) |
GlaxoSmithKline |
Abstract
|
Nigel Borshell, Taskin Ahmed |
|
Vol 2012, No 4 (2012) |
GlaxoSmithKline |
Abstract
|
Heather Cartwright, Taskin Ahmed |
|
Vol 2013, No 1 (2013) |
GlaxoSmithKline |
Abstract
|
Heather Cartwright |
|
Vol 2012, No 3 (2012) |
GSK Moves up the M&A Rankings |
Abstract
|
Nigel Borshell, Taskin Ahmed |
|
Vol 2011, No 1 (2011) |
Johnson & Johnson |
Abstract
|
Nigel Borshell |
|
Vol 2011, No 2 (2011) |
Johnson & Johnson |
Abstract
|
Nigel Borshell |
|
Vol 2011, No 3 (2011) |
Johnson & Johnson |
Abstract
|
Nigel Borshell |
|
Vol 2011, No 4 (2011) |
Johnson & Johnson |
Abstract
|
Nigel Borshell |
|
Vol 2011, No 5 (2011) |
Johnson & Johnson |
Abstract
|
Nigel Borshell |
|
51 - 75 of 143 Items |
<< < 1 2 3 4 5 6 > >> |